Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection

Virulence

Volumn 1, Issue 5, 2010, Pages 395-398

  Hutt Fletcher, Lindsey M ^a   Chesnokova, Liudmila S ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Epithelial cells; Epstein barr virus; Glyco proteins; Integrins; Nasopharyngeal carcinoma; Virus fusion

Indexed keywords

HLA ANTIGEN CLASS 2; INTEGRIN;

ARTICLE; CELL MEMBRANE; CELL TYPE; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; VIRUS VIRULENCE;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 78349245225     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.5.12546     Document Type: Article

References (30)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins 2007; 2:2655-2700.
2. Laichalk LL, Thorley-Lawson DA. Terminal dif-ferentiation into plasma cells initiated the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005; 79:1296-1307.
3. Jiang R, Scott RS, Hutt-Fletcher LM. Epstein-Barr virus shed in saliva is high in B cell tropic gp42. J Virol 2006; 80:7281-7283.
4. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009; 7:10000496.
5. White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 2008; 43:189-219.
6. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006; 313:217-220.
7. Atanasiu D, Whitbeck JC, de Leon MP, Lou H, Cohen GH, Eisenberg RJ. Bimolecular complemen-tation defines functional regions of Herpes simplex virus gB that are involved with H/gL as a necessary step leading to fusion. J Virol 2010; 84:3825-3834.
8. Subramanian RP, Geraghty RJ. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L and B. Proc Natl Acad Sci USA 2007; 104:2903-2908.
9. Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nature Med 2002; 8:594-599.
10. Miller N, Hutt-Fletcher LM. Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol 1992; 66:3409-3414.
11. Wu L, Hutt-Fletcher LM. Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology 2007; 363:148-155.
12. Wang X, Kenyon WJ, Li QX, Mullberg J, Hutt-Fletcher LM. Epstein-Barr virus uses different com-plexes of glycoproteins gH and gL to infect B lympho-cytes and epithelial cells. J Virol 1998; 72:5552-5558.
13. Li QX, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B, et al. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 1997; 71:4657-4662.
14. Kirschner AN, Sorem J, Longnecker R, Jardetzky TS. Structure of Epstein-Barr virus glycoprotein gp42 suggests a mechanism for triggering receptor-activated virus entry. Structure 2009; 17:223-233.
15. Borza CM, Morgan AJ, Turk SM, Hutt-Fletcher LM. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J Virol 2004; 78:5007-5014.
16. Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 2002; 31:485-516.
17. Burman A, Clark S, Abrescia NGA, Fry EE, Stuart DI, Jackson T. Specificity of the VP1 GH loop of Foot-and-Mouth Disease Virus for αv integrins. J Virol 2006; 80:9798-810.
18. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, et al. The integrin αvβ8 mediates epithelial homeostasis through MT-1-MMP-dependent activation of TGF-β1. J Cell Biol 2002; 157:493-507.
19. Stewart PL, Nemerow GR. Cell integrins: commonly used receptors for diverse pathogens. Trends Microbiol 2007; 15:500-507.
20. Xiao J, Palefsky JM, Herrera R, Tugizov SM. Characterization of the Epstein-Barr virus glycopro- tein BMRF2. Virology 2007; 359:382-396.
21. Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH, et al. Changing epidemiology of nasopharyn-geal carcinoma in Hong Kong over a 20-year period (1980-1999): an encouraging reduction in both inci- dence and mortality. Int J Cancer 2003; 103:680-685.
22. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular prolferation. Cell 1986; 47:883-889.
23. Moody CA, Scott RS, Su T, Sixbey JW. Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol 2003; 77:8555-8561.
24. Yeung WM, Zong YS, Chiu CT, Sham JS, Choy DT, Ng MH. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993; 53:746-750.
25. Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JY, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody- positive persons in Wuzhou City, China. Int J Cancer 1985; 36:545-547.
26. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12:451-462.
27. Thomas GJ, Nystrom ML, Marshall JF. αvβ6 integ- rin in wound healing and cancer of the oral cavity. J Oral Path Med 2006; 35:1-10.
28. Sheppard D. Integrin-mediated activation of latent transforming growth factor β. Cancer Metastasis Rev 2005; 24:395-402.
29. Munger JS, Huang X, Kawakatsu H, Griffiths MJD, Garat C, Matthay MA, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96:319-328.
30. Liang CL, Chen JL, Hsu YPP, Ou JT, Chang YS. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-β through cooperativity of Smads and c-Jun/c-Fos proteins. J Biol Chem 2002; 277:23345-2357.